RxDoctor Payments DataLook up a doctor →

Brad Mallory, MD

Family Medicine · Glasgow, KYNPI 1417129982

Payments from drug & device makers

$31,078in general payments, 2019–2025

Across 779 payments — averaging $39.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pfizer$16K
  • AbbVie$5K
  • Amgen$1K
  • Boehringer Ingelheim$1K
  • Lilly USA, LLC$1K
  • Novo Nordisk$819
  • plus $6K from 35 others

What the payments were for

  • Speaking & faculty fees$16,55053%
  • Travel & lodging$1,6425%
  • Food & beverage$12,86641%
  • Education$200%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$31,078 in reported general payments places this provider in the 95th percentile of 1,559 family medicine providers in Kentucky.

See all family medicine providers in Kentucky

Medicare billing

Part B allowed, 2024
$121,815
Medicare patients
438
Services billed
1,407

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide221$211,632
EliquisApixaban225$204,998
JardianceEmpagliflozin179$195,906
JanuviaSitagliptin Phosphate105$110,283
FarxigaDapagliflozin Propanediol66$69,418
Tresiba Flextouch U-200Insulin Degludec43$62,263
KerendiaFinerenone53$58,979
XareltoRivaroxaban61$43,846
Trelegy ElliptaFluticasone/Umeclidin/Vilanter53$41,020
TradjentaLinagliptin31$38,792
MounjaroTirzepatide27$33,183
LinzessLinaclotide31$22,032
Repatha SyringeEvolocumab28$15,443
VascepaIcosapent Ethyl29$14,782
SynthroidLevothyroxine Sodium172$13,720

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance, Tradjenta$1,243$234,697210 claims
Novo NordiskOzempic$819$211,632221 claims
PfizerEliquis, Abrysvo$15,625$210,097243 claims
MerckJanuvia, Belsomra$631$117,427118 claims
AstraZenecaFarxiga, Symbicort, Brilinta$723$87,912106 claims
GSKTrelegy Ellipta, Arexvy, Breo Ellipta, Shingrix, Anoro Ellipta$236$82,680177 claims
BayerKerendia$288$58,97953 claims
Johnson & JohnsonXarelto, Invokana$623$56,83672 claims
AbbVieLinzess, Synthroid$4,750$35,752203 claims
Lilly USA, LLCMounjaro$1,006$33,18327 claims
Astellas Pharma US IncMyrbetriq$306$7,52811 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,559 family medicine providers in Kentucky.

Other family medicine in Glasgow

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →